⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GMAB News
Genmab A/S ADS
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
globenewswire.com
GMAB
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S ®) in Combination with Bevacizumab in Advanced Ovarian Cancer
businesswire.com
GMAB
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
globenewswire.com
GMAB
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
globenewswire.com
GMAB
Major Shareholder Announcement
globenewswire.com
GMAB
Major Shareholder Announcement
globenewswire.com
GMAB
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
globenewswire.com
GMAB
Passing of Genmab A/S’ Annual General Meeting
globenewswire.com
GMAB
Genmab Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress
globenewswire.com
GMAB
Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023
globenewswire.com
GMAB
ABBV